The tRNA epitranscriptome: a novel player in viral infections
Recent evidence indicates that codon usage bias regulates gene expression, as synonymous codons are not decoded with the same efficiency. Viruses are entirely dependent on the host translation machinery to express their proteins....
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
FJC2020-044798-I
The tRNA epitranscriptome: a novel player in viral infection...
Cerrado
BFU2008-01216
FUNCIONES DERIVADAS DE LA TRANSCRIPCION Y SU REGULACION
97K€
Cerrado
MOVIRNA
Non-canonical modification of viral RNA
2M€
Cerrado
T-FRAME
Real time analysis of ribosomal frameshifting and its impact...
1M€
Cerrado
BFU2012-31861
NUEVOS MECANISMOS DE INICIACION DE LA TRADUCCION DE MRNAS VI...
159K€
Cerrado
BIO2009-12004
ANALISIS FUNCIONAL DE LA ACTIVIDAD REGULADORA DE PEQUEÑOS RN...
217K€
Cerrado
Información proyecto EpiCoVs
Duración del proyecto: 34 meses
Fecha Inicio: 2022-06-20
Fecha Fin: 2025-04-30
Descripción del proyecto
Recent evidence indicates that codon usage bias regulates gene expression, as synonymous codons are not decoded with the same efficiency. Viruses are entirely dependent on the host translation machinery to express their proteins. Puzzlingly, the genomes of diverse viruses synthesize viral proteins at high levels, such as those of the emerging Chikungunya virus (CHIKV), dengue virus (DENV) and the pandemic SARS-CoV-2 are enriched in rare codons that should slow down their translation. How these viruses achieve this high protein expression remains a fundamental question in virology. In Juana Díez's laboratory, recent findings have revealed an unprecedented interplay of the Chikungunya virus (CHIKV) with the host tRNA epitranscriptome. CHIKV adapts the host translational machinery toward viral codon usage by overexpressing a tRNA modification enzyme that favors translating a specific set of codons enriched in CHIKV RNA.
The proposed project will combine cellular, and molecular biology approaches with -omics analyses to further develop this novel research area and explore its translatability. First, using SARS-CoV-2 as a model, we will study whether the observed CHIKV-induced codon-specific reprogramming of the host translation machinery represents a common mechanism to optimize viral protein expression. Second, we will characterize the tRNA modifying enzymes involved. Third, we will explore the antiviral therapeutic interest of the identified enzymes. Together, these findings will shed light on a novel layer of virus-host interaction and might provide a rationale to consider the regulation of the host tRNA epitranscriptome as a promising target for the development of broad-spectrum antivirals.